New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new seven-country report designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities and develop effective strategies for the global coagulation testing market during the next five years.
The report explores business and technological trends in the US, Europe (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the test volume, as well as sales and market shares for leading instrument and reagent competitors; compares features of major analyzers; profiles leading market players; analyzes potential applications of emerging technologies; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the global coagulation diagnostics practice during the next five years. New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.
France, Germany, Italy, Japan, Spain, UK, USA
Worldwide Market Overview
- Comprehensive market segmentation analysis, including review
of the market dynamics, structure, size, growth and major suppliers
- Estimated universe of facilities performing coagulation tests
- Five-year test volume and sales projections by country.
Business Opportunities and Strategic Recommendations
- Product development and business expansion
opportunities with significant market appeal.
- Ideal product models with tentative
prices and operating characteristics.
- Alternative market penetration
strategies for instrument and reagent suppliers.
- Potential market entry barriers and risks.
Current and Emerging Coagulation Tests
Activated Clotting Time (ACT) (1), Activated Protein C Resistance,
Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time,
D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX,
Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII,
Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation,
Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen,
Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S,
Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time,
Von Willebrand's Factor Fav/Ag, and others.
Sales and Market Share Analysis of Instrument and Reagent Suppliers
- Sales and market shares of major instrument
and consumable manufactures by country.
Market Segmentation Analysis
- Comprehensive market
segmentation analysis, including:
- Commercial/Private Laboratories
- Physician Offices
- Ambulatory Care Centers
- Test volume forecasts for over 40 major procedures,
by country and market segment.
Current and Emerging Products
- Review of established and new procedures.
- Comparison of automated and semi-automated
analyzers marketed by Diagnostica Stago, Helena, IL,
Roche, Siemens, Sysmex and other suppliers.
- Analysis of current and emerging technologies
and their potential market applications.
- Comprehensive lists of companies developing
or marketing new technologies and products by test.
- Strategic assessments ofmajor suppliers and start-up firms
developing innovative coagulation testing technologies
and products, including their sales, product portfolios,
marketing tactics, collaborative arrangements, and new products in R&D.
- The companies analyzed in the report include:
- ADI/American Diagnostica
- Beckman Coulter/Danaher
- Becton Dickinson
- Corgenix Medical
- Diagnostica Stago/Trinity Biotech
- Helena Laboratories
- Hyphen BioMed
- Instrumentation Laboratory
- ITC/Nexus Dx
- Thermo Fisher
Contains 650 pages and 150 tables
SIMILAR MARKET STUDIES
The report presents a detailed analysis of the Cryptosporidium diagnostics market in the US, Europe, France, Germany, Italy, Spain, UK and Japan. Current scientific views on the Cryptosporidium definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the ...
November 2013 | $2800 | View Details >>
In this report, the EMEA Rotational Rheometer market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, ...
April 2017 | $4000 | View Details >>
This report identifies major opportunities emerging in the flow cytometry market for new instruments, consumables, and auxiliary products; proposes ?ideal? product models with tentative prices and operating characteristics; and suggests alternative market penetration strategies for suppliers.Contains 8 pages
September 2015 | $0 | View Details >>
This report studies Whole Exome Sequencing in Global and China market, focuses on top manufacturers in global and China market, involving Whole Exome Sequencing price of each type, production, revenue and market share for each manufacturer. This report also displays the production, revenue and market share of Whole Exome Sequencing ...
July 2016 | $2900 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research